 |
(NaturalNews) Pharmaceutical giant Merck announced on September 2 that it is abandoning plans for a new osteoporosis drug known as odanacatib, after the latest phase of safety trials showed that the drug significantly raised patients' risk of stroke. The findings of that trial will... |
Merck stops production of osteoporosis drug over stroke concerns, has yet to stop vaccine production
Continue Reading
Bagikan Berita Ini
0 Response to "Merck stops production of osteoporosis drug over stroke concerns, has yet to stop vaccine production"
Post a Comment